Rasagiline recalls

The FDA has published 3 recalls involving Rasagiline since 2014. The latest was reported on 27 Sep 2023. Most were for labeling errors. Aurobindo Pharma USA has the most recalls in this group. Recalls usually affect specific lots, not every bottle on the market. Check the lot number on each recall page before acting.

Total recalls3since 2014

Last 12 months0reported

Class I00% of total

Ongoing0latest 27 Sep 2023

Recalls per month, last 24 months

click a bar for that month

0Nov '24 0 0 0Feb 0 0 0May 0 0 0Aug 0 0 0Nov 0 0 0Feb 0 0 0May 0 0 0Aug 0 0

Severity split

Class I 0 0%Class II 3 100%Class III 0 0%

Why rasagiline is recalled

Companies

By year

2023267%
2014133%

All rasagiline recalls, newest first

3 total

Reported	Class	Recall	Company	Reason	Where
27 Sep 2023Drug	CLASS II	Rasagiline Tablets 0.5mg recalled by Aurobindo Pharma USA	Aurobindo Pharma USA	Potency & Assay	Nationwide
25 Jan 2023Drug	CLASS II	Rasagiline Mesylate Tablets 1 mg; in HDPE recalledRasagiline	Ascend Laboratories	Other	20 states
22 Jan 2014Drug	CLASS II	Rasagiline Mesylate, Tablet, 0.5 mg recalled by Aidapak Services	Aidapak Services	Labeling Errors	4 states

Should you stop taking Rasagiline?

Not on your own. Most recalls affect specific lots from one manufacturer, and stopping a prescription suddenly can be riskier than the defect. Check your lot number and NDC against the recall, then call the pharmacy that dispensed it for a replacement.